Pre-treatment lymphocytopaenia is an adverse prognostic biomarker in muscle-invasive and advanced bladder cancer.
about
Prognostic value of inflammation-based scores in patients with osteosarcoma.Immunological tumor status may predict response to neoadjuvant chemotherapy and outcome after radical cystectomy in bladder cancer.Preoperative prognostic nutritional index and nomogram predicting recurrence-free survival in patients with primary non-muscle-invasive bladder cancer without carcinoma in situ.Peripheral inflammation/immune indicators of chemosensitivity and prognosis in breast cancer patients treated with neoadjuvant chemotherapy.Prognostic impact of leukocyte counts before and during radiotherapy for oropharyngeal cancer.Reduction of circulating lymphocyte count is a predictor of good tumor response after neoadjuvant treatment for rectal cancerBiomarkers for Predicting Clinical Outcomes of Chemoradiation-Based Bladder Preservation Therapy for Muscle-Invasive Bladder Cancer
P2860
Q37529300-01A1F72A-6FDA-446D-A8FD-786FF2BCFB73Q42237188-92EDAAF7-66D5-416D-A57E-645E2DA6D6CEQ47097234-41CBB9C8-9EC2-4ECD-80A8-0BF666058BE9Q52626663-22C696BD-2244-4100-8D39-6E5090662E63Q55083592-F2457832-225F-4602-97A6-818653D400E9Q58704497-9EA69962-8E87-41CD-A00F-04196ED19B5AQ58736803-54B8C7FB-8DC4-48A1-9EA5-923FBB647D03
P2860
Pre-treatment lymphocytopaenia is an adverse prognostic biomarker in muscle-invasive and advanced bladder cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Pre-treatment lymphocytopaenia ...... e and advanced bladder cancer.
@en
type
label
Pre-treatment lymphocytopaenia ...... e and advanced bladder cancer.
@en
prefLabel
Pre-treatment lymphocytopaenia ...... e and advanced bladder cancer.
@en
P2093
P2860
P50
P356
P1433
P1476
Pre-treatment lymphocytopaenia ...... ve and advanced bladder cancer
@en
P2093
P2860
P304
P356
10.1093/ANNONC/MDV546
P577
2015-11-16T00:00:00Z